VHT 0.00% $1.15 volpara health technologies limited

General Discussion, page-84

  1. 1,287 Posts.
    lightbulb Created with Sketch. 233
    The following excerpt was taken from slide 8 of a Volpara presentation lodged 2nd September.

    ARPU for VolparaEnterprise alone has been rising organically, and in FY19 was US$2.20, 37% higher than FY18. In Q1, contracts signed ranged up to an ARPU of US$7 – the aim with MRS and other products is to get to US$10 and beyond.

    https://wcsecure.weblink.com.au/pdf/VHT/02142146.pdf

    So we can see intention is to lift over time the average revenue per user to US$10 with the benefit of the MRS acquisition. I don’t have a break even forecast but believe the size of the opportunity makes that possible with proper execution.
    Last edited by lightning70: 15/10/19
 
watchlist Created with Sketch. Add VHT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.